Home Articles List Article Information
International Journal of New Chemistry
Journal Archive
Volume Volume 6 (2019)
Volume Volume 5 (2018)
Volume Volume 4 (2017)
Volume Volume 3 (2016)
Volume Volume 2 (2015)
Volume Volume 1 (2014)
Sartipi, M. (2016). Ab Initio Studies: effect of various substituted on structural parameters and charge transfer energy of the Nafazolin drug and its nano carrier on fullerene. International Journal of New Chemistry, 3(2), 56-62.
Maryam Sartipi. "Ab Initio Studies: effect of various substituted on structural parameters and charge transfer energy of the Nafazolin drug and its nano carrier on fullerene". International Journal of New Chemistry, 3, 2, 2016, 56-62.
Sartipi, M. (2016). 'Ab Initio Studies: effect of various substituted on structural parameters and charge transfer energy of the Nafazolin drug and its nano carrier on fullerene', International Journal of New Chemistry, 3(2), pp. 56-62.
Sartipi, M. Ab Initio Studies: effect of various substituted on structural parameters and charge transfer energy of the Nafazolin drug and its nano carrier on fullerene. International Journal of New Chemistry, 2016; 3(2): 56-62.

Ab Initio Studies: effect of various substituted on structural parameters and charge transfer energy of the Nafazolin drug and its nano carrier on fullerene

Article 3, Volume 3, Issue 2, Spring 2016, Page 56-62  XML PDF (1.25 MB)
Document Type: Research Paper
Author
Maryam Sartipi*
Department of Organic Chemistry, Faculty of Chemistry, University of Mazandaran, Babolsar, Iran.
Abstract
A fullerene is any molecule composed entirely of carbon, in the form of a hollow sphere.Naphazoline is a sympathomimetic agent with marked alpha adrenergic activity. It is a vasoconstrictor with a rapid action in reducing swelling when applied to mucous membrane. It acts on alpha-receptors in the arterioles of the conjunctiva to produce constriction, resulting in decreased congestion. It is an active ingredient in several over-the-counter formulations including Clear Eyes and Naphcon eye drops.In this research work at The first compounds [C60-Nafazolin-Cn-2X]+ and [Nafazolin-Cn-2X]+ (X=F,Cl,Br) were optimized. Then the calculation of natural bond orbitals was performed with the NBO technique. All calculations using Hartree- fock  the 6-31G * basis set using Gaussian 98 software and in gas phase has been done. The results showed that the energy levels of molecular orbital (HOMO & LUMO) in the RF has the lowest value. C65-X has a length of the shortest bond and the bond has most power. Comparison of the dipole moments of compounds shows this trend: RF> R-Cl> R-Br but to be noticed that with same trend in nano carrier dipole moment is reducing. The values of Charge transfer energy for  σ              σ*  (C7 - X26               C5 - N6 ) show this order R-Br> R-Cl > R-F
Keywords
Nafazolin; nano carrier; fullerene; charge transfer energy
References
1)    R. Ahmadi, K. Kalateh, V. Amani, Acta. Crystallogr. E., 66, m959 (2010).

2)    M. Monajjemi, R. Ahmadi, K. Zare, E. Rejaian, J. Phys. Theor. Chem., 3, 17 (2006).

3)    M. Monajjemi, M. Heshmat, H. Aghaei, R. Ahmadi, K. Zare, Bull. Chem. Soc. Ethiop., 21, 111 (2007).

4)    M. D. Ganji, R. Ahmadi, J. Sci., 33, 33 (2007).

5)    S. Reihani, Z. Azizi, M. Khaleghian, H. Passdar, L. Pishkar, R. Ahmadi, L. Saedi,  J. Phys. Theor. Chem., 4, 51 (2007).

6)    M. Yousefi, R. Ahmadi, V. Amani, H. R. Khavasi, Acta. Crystallogr. E., 63, m3114 (2007).

7)    R. Ahmadi, A. Ebadi, K. Kalateh, A. Norouzic, V. Amani, Acta. Crystallogr. E., 64, m1407 (2008).

8)    M. Monajjemi, R. Ahmadi, F. Mollaamin, M. Khaleghian, B. K. Hadad, Int. J. Appl. Chem., 4, 171 (2008).

9)    R. Ahmadi, V. Amani, H. R. Khavasi, Acta. Crystallogr. E., 64, m1156 (2008).

10) A. Khalighi, R. Ahmadi, V. Amani, H. R. Khavasi, Acta. Crystallogr. E., 64, m1211 (2008).

11) R. Ahmadi, K. Kalateh, A. Abedi, V. Amani, H. R. Khavasi, Acta. Crystallogr. E., 64, m1306 (2008).

12) R. Ahmadi, L. Dehghan, V. Amani, H. R. Khavasi, Acta. Crystallogr. E., 64, m1237 (2008).

13)  R. Ahmadi, K. Kalateh, A. Ebadi, V. Amani, H. R. Khavasi, Acta. Crystallogr. E., 64, m1266 (2008).

14)  R. Ahmadi, A. Khalighi, K. Kalateh, V. Amani, H. R. Khavasi, Acta. Crystallogr. E., 64, m1233 (2008).

15) K. Kalateh, R. Ahmadi, A. Ebadi, V. Amani, H. R. Khavasi, Acta. Crystallogr. E., 64, m1353 (2008).

16) K. Kalateh, A. Ebadi, R. Ahmadi, V. Amani, H. R. Khavasi, Acta. Crystallogr. E., 64, m1397 (2008).

17) R. Ahmadi, A. Ebadi, K. Kalateh, A. Norouzi, V. Amani, Acta. Crystallogr. E., 64, m1407 (2008).

18) K. Kalateh, A. Norouzi, A. Ebadi, R. Ahmadi, V. Amani, Acta. Crystallogr. E., 64, m1583 (2008).

19) R. Alizadeh, A. Heidari, R. Ahmadi, V. Amani, Acta. Crystallogr. E., 65, m483 (2009).

20) Z. Khoshtarkib, A. Ebadi, R. Alizadeh, R. Ahmadi, V. Amani, Acta. Crystallogr. E., 65, m739 (2009).

21) Z. Khoshtarkib, A. Ebadi, R. Ahmadi, R. Alizadeh, Acta. Crystallogr. E., 65, o1586 (2009).

22) R. Ahmadi, K. Kalateh, R. Alizadeh, Z. Khoshtarkib, V. Amani, Acta. Crystallogr. E., 65, m848 (2009).

23) R. Ahmadi, K. Kalateh, R. Alizadeh, Z. Khoshtarkib, V. Amani, Acta. Crystallogr. E., 65, m1169 (2009).

24) R. Alizadeh, K. Kalateh, A. Ebadi, R. Ahmadi, V. Amani, Acta. Crystallogr. E., 65, m1250 (2009).

25) R. Alizadeh, K. Kalateh, Z. Khoshtarkib, R. Ahmadi, V. Amani, Acta. Crystallogr. E., 65, m1439 (2009).

26) K. Kalateh, R. Ahmadi, V. Amani, Acta. Crystallogr. E., 66, m512 (2010).

27)  R. Ahmadi, K. Kalateh, V. Amani, Acta. Crystallogr. E., 66, m562 (2010).

28) R. Ahmadi, K. Kalateh, V. Amani, Acta. Crystallogr. E., 66, m959 (2010).

29) K. Kalateh, R. Ahmadi, V. Amani, Acta. Crystallogr. E., 66, m1241 (2010).

30) R. Ahmadi, R. Soleymani, T. Yousofzad, Orient. J. Chem., 28, 773 (2012).

31) R. Ahmadi, J. Phys. Theor. Chem., 9, 185 (2012).

32) E. Fereyduni, M. Kamaee, R. Soleymani, R. Ahmadi, J. Theor. Comput. Chem., 11, 1331 (2012)

33) R. Ahmadi, R. Soleymani, J. Phys. Theor. Chem., 10, 201 (2013).

34) R. Ahmadi, M. Pirahan-foroush, Ann. Mil. Health. Sci. Res., 12, 86 (2014).

35) R. Ahmadi, M. Pirahan-foroush, Ann. Mil. Health. Sci. Res., 12, 39 (2014).

36) R. Ahmadi, R. Soleymani, Orient. J. Chem., 30, 57 (2014).

37) R. Ahmadi, M. D. Ganji, Int. J. New. Chem., 1, 10 (2014).

38) R. Ghiasi, R. Ahmadi, Int. J. New. Chem., 1, 30 (2014).

39) R. Ahmadi, E. Farajpour, Ce. N., 37, 6 (2015).

40) R. Ahmadi, M. Salmaniha, Int. J. New. Chem., 4, 152 (2015).

41) R. Ahmadi, T. Boroushaki, M. Ezzati, Int. J. Nano. Dimens., 6, 19 (2015).

42) R. Ahmadi, S. Pourkarim, Int. J. Bio-Inorg. Hybr. Nanomater., 4, 249 (2015).

Statistics
Article View: 4